Results

1–10 of 199 results for outcomes

Early Treatment Patterns and Outcomes in Patients With Neovascular Age-Related Macular Degeneration Initiating Faricimab: The FARETINA-AMD Study
Theodore Leng, MD, MS, FASRS
Annual Meeting Talks
2023
Additional Visual and Anatomic Outcomes of Intravitreal Aflibercept Injection, 8 mg vs 2 mg: Post Hoc Analysis of the Phase 2 CANDELA Study
Priya Sharma Vakharia, MD
Annual Meeting Talks
2023
Early Treatment Patterns and Outcomes in Patients With Diabetic Macular Edema Treated With Faricimab: FARETINA-DME Study
Durga Borkar, MD
Annual Meeting Talks
2023
Four-Year Visual Outcomes in the Protocol W Randomized Trial of Intravitreous Aflibercept for Prevention of Vision-Threatening Complications of Diabetic Retinopathy
Hani Salehi-Had, MD, FASRS
Annual Meeting Talks
2023
Time Course of Outer Retinal Restoration Afyer Vitrectomy for Fovea-off Rhegmatogenous Retinal Detachments
Bryon McKay, MD, PhD, FRCSC
Annual Meeting Talks
2023
Long-Term Visual and Anatomic Outcomes of Internal Limiting Membrane Flap vs Internal Limiting Membrane Peeling for Large, Full-Thickness Macular Holes
Ankoor R Shah, MD, FASRS
Annual Meeting Talks
2023
Bevacizumab-First vs Real-World Cost Outcomes for Diabetic Macular Edema: 2-Year Cost Analysis Modeled on DRCR Protocol AC Results
Dilraj S Grewal, MD, FASRS
Annual Meeting Talks
2023
Impact and Outcomes of Anti-VEGF Prior Authorization Requests: Insights From a Large Database Analysis
Saira Khanna, MD
Annual Meeting Talks
2023
Outcomes of Children With Autosomal Dominant Neovascular Inflammatory Vitreoretinopathy
Arjun B Sood, MD
Annual Meeting Talks
2023
Demographic and Socioeconomic Predictors of Visual Outcomes in Pediatric Uveitis: An IRIS Registry Study
Akshay S Thomas, MD, MS, FASRS
Annual Meeting Talks
2023